Disposition of dobutamine in the dog.
The disposition of dobutamine, a potent inotropic catecholamine, has been examined in the dog. A sensitive assay has been developed for dobutamine allowing the measurement of the drug at plasma concentrations as low as 1 ng/ml. The short plasma half-life of dobutamine from the plasma to the tissue. When 14C-dobutamine was administered, the plasma half-life of radioactivity was 1.9 hours. The circulating radioactivity consists mainly of the glucuronide conjugate of 3-O-methyldobutamine. During continuous intravenous administration of dobutamine, plasma levels of metabolites reached a maximum between 3 and 4 hours. During a 48-hour time period after administration of 14C-dobutamine, 67% of the radiolable was excreted in the urine and 20% in the feces. In dogs having cannulated bile ducts, 30 to 35% of the administered drug was excreted in the bile. The major urinary metabolites were the glucuronide conjugates of dobutamine and 3-O-methyldobutamine.
D000818:Animals; D001646:Bile / Q000378:metabolism; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism*; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D004280:Dobutamine / Q000008:administration & dosage / Q000378:metabolism*; D004285:Dogs; D005243:Feces / Q000032:analysis; D005260:Female; D005965:Glucuronates / Q000096:biosynthesis; D007263:Infusions, Parenteral; D013058:Mass Spectrometry; D008722:Methods; D008745:Methylation; D013997:Time Factors
D002395:Catecholamines; D005965:Glucuronates; D004280:Dobutamine; D002394:Catechol O-Methyltransferase